Obesity and the gut microbiota: implications of neuroendocrine and immune signaling

被引:7
作者
Romani-Perez, Marina [1 ]
Liebana-Garcia, Rebeca [1 ]
Flor-Duro, Alejandra [1 ]
Bonillo-Jimenez, Daniel [1 ]
Bullich-Vilarrubias, Clara [1 ]
Olivares, Marta [1 ]
Sanz, Yolanda [1 ]
机构
[1] Spanish Natl Res Council IATA CSIC, Inst Agrochem & Food Technol, Valencia, Spain
关键词
diet; enteroendocrine hormones; gut microbiota; inflammation; obesity; CHAIN FATTY-ACIDS; PROTEIN-COUPLED RECEPTOR; ENTEROENDOCRINE CELLS; PEPTIDE-YY; INTESTINAL MICROBIOTA; INSULIN SENSITIVITY; METABOLIC SYNDROME; BODY-WEIGHT; GLP-1; SECRETION;
D O I
10.1111/febs.17249
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity is a major health challenge due to its high prevalence and associated comorbidities. The excessive intake of a diet rich in fat and sugars leads to a persistent imbalance between energy intake and energy expenditure, which increases adiposity. Here, we provide an update on relevant diet-microbe-host interactions contributing to or protecting from obesity. In particular, we focus on how unhealthy diets shape the gut microbiota and thus impact crucial intestinal neuroendocrine and immune system functions. We describe how these interactions promote dysfunction in gut-to-brain neuroendocrine pathways involved in food intake control and postprandial metabolism and elevate the intestinal proinflammatory tone, promoting obesity and metabolic complications. In addition, we provide examples of how this knowledge may inspire microbiome-based interventions, such as fecal microbiota transplants, probiotics, and biotherapeutics, to effectively combat obesity-related disorders. We also discuss the current limitations and gaps in knowledge of gut microbiota research in obesity. An unhealthy diet impairs the symbiotic relationship between the gut microbiota and the host, contributing to obesity. At the intestinal level, identification of host-microbe events essential for proper neuroendocrine/immune signaling is key to the development of microbiome-based strategies to promote metabolic health in obesity (probiotics, biotherapeutic products, and fecal microbiota transplantation). These strategies may help restore food sensing and so, eating behavior, and confer protection against intestinal and systemic inflammation. image
引用
收藏
页码:1397 / 1420
页数:24
相关论文
共 181 条
[1]   Identification of new enterosynes using prebiotics: roles of bioactive lipids and mu-opioid receptor signalling in humans and mice [J].
Abot, Anne ;
Wemelle, Eve ;
Laurens, Claire ;
Paquot, Adrien ;
Pomie, Nicolas ;
Carper, Deborah ;
Bessac, Arnaud ;
Orea, Xavier Mas ;
Fremez, Christophe ;
Fontanie, Maxime ;
Lucas, Alexandre ;
Lesage, Jean ;
Everard, Amandine ;
Meunier, Etienne ;
Dietrich, Gilles ;
Muccioli, Giulio G. ;
Moro, Cedric ;
Cani, Patrice D. ;
Knauf, Claude .
GUT, 2021, 70 (06) :1078-1087
[2]   GLP-1-based therapy of type 2 diabetes: GLP-1 mimetics and DPP-IV inhibitors [J].
Ahrén B. .
Current Diabetes Reports, 2007, 7 (5) :340-347
[3]   Effects of Probiotics and Synbiotics on Weight Loss in Subjects with Overweight or Obesity: A Systematic Review [J].
Alvarez-Arrano, Valentina ;
Martin-Pelaez, Sandra .
NUTRIENTS, 2021, 13 (10)
[4]   A Keystone Gut Bacterium Christensenella minuta-A Potential Biotherapeutic Agent for Obesity and Associated Metabolic Diseases [J].
Ang, Wei-Shan ;
Law, Jodi Woan-Fei ;
Letchumanan, Vengadesh ;
Hong, Kar Wai ;
Wong, Sunny Hei ;
Ab Mutalib, Nurul Syakima ;
Chan, Kok-Gan ;
Lee, Learn-Han ;
Tan, Loh Teng-Hern .
FOODS, 2023, 12 (13)
[5]  
[Anonymous], 2000, Obesity: Preventing and Managing the Global Epidemic, DOI DOI 10.1596/0-1952-1129-4
[6]   Microbial regulation of the L cell transcriptome [J].
Arora, Tulika ;
Akrami, Rozita ;
Pais, Ramona ;
Bergqvist, Linda ;
Johansson, Bengt R. ;
Schwartz, Thue W. ;
Reimann, Frank ;
Gribble, Fiona M. ;
Backhed, Fredrik .
SCIENTIFIC REPORTS, 2018, 8
[7]   Trimethylamine-N-oxide (TMAO) as Novel Potential Biomarker of Early Predictors of Metabolic Syndrome [J].
Barrea, Luigi ;
Annunziata, Giuseppe ;
Muscogiuri, Giovanna ;
Di Somma, Carolina ;
Laudisio, Daniela ;
Maisto, Maria ;
de Alteriis, Giulia ;
Tenore, Gian Carlo ;
Colao, Annamaria ;
Savastano, Silvia .
NUTRIENTS, 2018, 10 (12)
[8]   Lactobacillus gasseri in the Upper Small Intestine Impacts an ACSL3-Dependent Fatty Acid-Sensing Pathway Regulating Whole-Body Glucose Homeostasis [J].
Bauer, Paige V. ;
Duca, Frank A. ;
Waise, T. M. Zaved ;
Dranse, Helen J. ;
Rasmussen, Brittany A. ;
Puri, Akshita ;
Rasti, Mozhgan ;
O'Brien, Catherine A. ;
Lam, Tony K. T. .
CELL METABOLISM, 2018, 27 (03) :572-+
[9]   Metformin Alters Upper Small Intestinal Microbiota that Impact a Glucose-SGLT1-Sensing Glucoregulatory Pathway [J].
Bauer, Paige V. ;
Duca, Frank A. ;
Waise, T. M. Zaved ;
Rasmussen, Brittany A. ;
Abraham, Mona A. ;
Dranse, Helen J. ;
Puri, Akshita ;
O'Brien, Catherine A. ;
Lam, Tony K. T. .
CELL METABOLISM, 2018, 27 (01) :101-+
[10]   The anti-inflammatory and immunological properties of GLP-1 Receptor Agonists [J].
Bendotti, Giulia ;
Montefusco, Laura ;
Lunati, Maria Elena ;
Usuelli, Vera ;
Pastore, Ida ;
Lazzaroni, Elisa ;
Assi, Emma ;
Seelam, Andy Joe ;
El Essawy, Basset ;
Jang, Jun ;
Loretelli, Cristian ;
D'Addio, Francesca ;
Berra, Cesare ;
Ben Nasr, Moufida ;
Zuccotti, GianVincenzo ;
Fiorina, Paolo .
PHARMACOLOGICAL RESEARCH, 2022, 182